CHICAGO — In this Healio Video Perspective from the AAO meeting, Jennifer I. Lim, MD, discusses the year 1 and year 2 data for faricimab for the treatment of age-related macular degeneration and diabetic macular edema.
According to Lim, treatment with faricimab resulted in improvements in visual acuity and reductions in the central subfield thickness and demonstrated extended durability.